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Abstract: Multi-target strategies are directed toward targets that are unrelated (or distantly 
related) and can create opportunities to address different pathologies. The antidermatophytic 
activities of nine natural skin lighteners: α-bisabolol, kojic acid, β-arbutin, azelaic acid, 
hydroquinone, nicotinamide, glycine, glutathione and ascorbyl tetraisopalmitate, were 
evaluated, in comparison with the known antifungal drug fluconazole, on nine dermatophytes 
responsible for the most common dermatomycoses: Microsporum gypseum, Microsporum 
canis, Trichophyton violaceum, Nannizzia cajetani, Trichophyton mentagrophytes, 
Epidermophyton floccosum, Arthroderma gypseum, Trichophyton rubrum and Trichophyton 
tonsurans. α-Bisabolol showed the best antifungal activity against all fungi and in particular; 
against M. gypseum. Further investigations were conducted on this fungus to evaluate the 
inhibition of spore germination and morphological changes induced by α-bisabolol by TEM. 
Keywords: antifungal activity; dermatophytes; M. gypseum; α-bisabolol; TEM; skin lightener 
 
OPEN ACCESS




The skin is our first line of defense against the outside world. As the body’s border, it is subject to 
various microbiological attacks. In particular, approximately 25% of the world’s population suffers 
from skin mycosis [1], which represents one of the main causes of morbidity and mortality [2] and the 
seriousness of the disease is steadily increasing. Dermatophytoses are very fastidious and difficult to 
manage, and their therapy is complex and associated with high costs. Our research group has long been 
involved in the search for new molecules with antifungal activity, exploring not only the fields of 
unknown natural [3–6] and synthetic [7–10] substances but also those substances already used in  
other clinical fields. Our main interest is in the discovery of molecules with multiple activities  
(multi-target-drugs), the advantages from such an approach include not only a better balance between 
activity and side effects but also a reduction in cost and time to develop and reach the market. If  
multi-target strategies are directed toward targets that are unrelated (or distantly related) an opportunity 
maybe created to target different pathologies. In these regards, it is well known that skin hyperpigmentation 
is a relevant problem, affects a large portion of the world’s population, and is a particular social issue 
for black and elderly people. This context has prompted the search for more effective treatments in 
dermatology and this problem is attributed to the over-accumulation of melanin in skin cells. Several 
molecules, mostly of natural origin, have been used over the last few years to counteract this effect. 
While the mechanisms of action are different, these molecules reduce melanin content. In a completely 
different field, melanin biosynthesis inhibitors have long been used for the control of plant pathogenic 
fungi [9,11,12]. We began an explorative investigation of these known melanin inhibitors, which may 
be used as antifungal agents in combination with known or investigational therapeutics. Agents that are 
typically used for dermatological purposes (e.g., skin lighteners), whose low toxicity, pharmacokinetics 
and pharmacodynamics are already known, will accelerate the process of developing innovative, less 
toxic and safer drug candidates. In particular, α-bisabolol, kojic acid, β-arbutin, azelaic acid, hydroquinone, 
nicotinamide, glycine, glutathione and ascorbyl tetraisopalmitate were selected. These nine molecules 
are already known in the literature for their action as skin lighteners [13–17] and are present in several 
commercial products. 
In this work, the antidermatophytic activity of these substances was tested on nine dermatophytes 
responsible for the most common dermatomycoses: Microsporum gypseum, Microsporum canis, 
Trichophyton violaceum, Nannizzia cajetani, Trichophyton mentagrophytes, Epidermophyton floccosum, 
Arthroderma gypseum, Trichophyton rubrum and Trichophyton tonsurans. 
After a preliminary investigation, α-bisabolol emerged as the most active compound; thus, the 
following experiments focused on this molecule and its effects on the most sensitive of the nine fungi, 
M. gypseum. This molecule (Figure 1) is a sesquiterpene alcohol found in the essential oils of several 
plants, such as Arnica longifolia, Aster esperius, Chrysothamnus nauseosus [18], and Chamomilla sp. [19], 
and its antibacterial and antifungal activities are well-known in the literature [20]. In particular, 
investigations were conducted by TEM to confirm whether the mechanism of action for the inhibition 
of ergosterol synthesis by α-bisabolol, as suggested by Pauli [19] for other fungi, was also responsible 
for its antifungal activity [21]. 




Figure 1. Chemical structure of α-bisabolol. 
2. Results and Discussion 
2.1. Antifungal Activity 
The growth inhibition data are shown in Table 1. 
Table 1. Percent growth inhibition of dermatophytes treated with nine skin lighteners at 
100 or 200 μg/mL. Each value is the mean of three measurements. 
  Kojic Acid β-Arbutin 
Azelaic 
Acid 




100 3.5 ± 0.1 7.9 ± 0.2 6.9 ± 0.2 17.1 ± 0.1 9.8 ± 0.1 79.8 ± 0.4 + + 16.6 ± 0.3 
200 7.5 ± 0.2 27.9 ± 0.1 19.8 ± 0.1 51.2 ± 0.1 18.3 ± 0.4 83.7 ± 0.2 0.8 ± 0.1 + 21.3 ± 0.2 
M. canis 
100 22.6 ± 0.3 −11.8 ± 0.2 −5.9 ± 0.1 20.0 ± 0.1 2.4 ± 0.1 34.7 ± 0.2 0.0 0.0 + 
200 29.0 ± 0.1 −2.9 ± 0.2 5.9 ± 0.3 46.7 ± 0.2 12.0 ± 0.1 43.1 ± 0.2 + 3.8 ± 0.3 + 
T. violaceum 
100 18.2 ± 0.2 −2.8 ± 1.4 −8.2 ± 0.9 20.0 ± 1.2 3.4 ± 1.8 31.0 ± 0.8 + 9.8 ± 2.3 + 
200 19. 9 ± 1.1 −5.0 ± 0.7 2.5 ± 1.6 30.6 ± 1.3 + 38.0 ± 1.8 0.0 12.0 ± 1.4 15.6 ± 2.0 
N. cajetani 
100 2.7 ± 1.1 6.9 ± 1.6 0.9 ± 1.9 0.0 14.4 ± 0.7 60.1 ± 1.3 0.0 + + 
200 8.0 ± 1.0 7.6 ± 1.4 0.0 4.2 ± 0.3 25.1 ± 0.6 62.7 ± 1.5 + 5.2 ± 1.3 0.0 
T. mentagroph 
100 0.0 −1.5 ± 0.5 0.0 29.7 ± 1.8 50.8 ± 1.8 67.0 ± 1.3 6.1 ± 0.6 + 9.8 ± 1.1 
200 6.3 ± 1.2 0.0 9.3 ± 0.8 59.4 ± 1.4 78.0 ± 3.1 70.9 ± 1.7 + + 19.6 ± 0.8 
E. floccosum 
100 1.9 ± 1.7 −1.6 ± 0.5 0.3 ± 0.1 2.5 ± 0.2 7.8 ± 0.7 31.8 ± 1.1 + 0.6 ± 0.2 + 
200 2.5 ± 0.9 −1.3 ± 0.5 3.9 ± 1.0 5.4 ± 0.8 + 33.1 ± 1.9 + 0.0 6.4 ± 0.9 
A. gypseum 
100 10.0 ± 1.2 0.0 7.4 ± 1.4 −11.0 ± 0.9 1.9 ± 1.2 62.0 ± 1.7 + 0.6 ± 2.1 0.7 ± 0.5 
200 11.3 ± 1.2 2.3 ± 1.8 3.7 ± 1.4 2.4 ± 1.1 7.1 ± 0.6 65.8 ± 1.3 + 1.3 ± 1.0 + 
T. rubrum 
100 −0.4 ± 0.8 6.1 ± 1.4 0.8 ± 0.5 −2.3 ± 1.9 4.5 ± 0.3 14.6 ± 1.9 + 2.6 ± 0.2 0.0 
200 2.9 ± 0.7 6.8 ± 1.3 1.6 ± 0.7 2.9 ± 0.6 10.8 ± 1.1 37.4 ± 1.4 + + + 
T. tonsurans 
100 0.0 4.4 ± 0.5 −2.6 ± 1.2 40.0 ± 1.1 9.3 ± 1.3 69.6 ± 1.9 + + + 
200 5.0 ± 0.5 11.1 ± 0.7 0.0 55.00 ± 1.5 + 71.7 ± 1.2 0.0 ± 0.8 + + 
In general, the nine substances showed low inhibition of growth. In fact, after treatment with  
β-arbutin, increased fungal growth was observed for M. canis and T. violaceum. The only substances 
that showed significant inhibition values were hydroquinone and α-bisabolol. The former showed 
inhibition values greater than 50% at the highest dose (200 μg/mL) for M. gypseum (51%), T. tonsurans 
(55%) and T. mentagrophytes (59.5%). At the lower dose (100 μg/mL), a 40% inhibition value was 
observed for T. tonsurans. When treated with 100 μg/mL α-bisabolol, at least 30% inhibition was observed 
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for all fungi, with the exception of T. rubrum. For both the lower and higher doses of α-bisabolol, 
inhibition was greater than 50% for five fungi (M. gypseum, N. cajetani, T. mentagrophytes, T. tonsurans 
and A. gypseum). In particular, T. mentagrophytes and T. tonsurans were sensitive to treatment, 
reaching approximately 70% inhibition for both dose levels. For treatments with 100 μg/mL and  
200 μg/mL of α-bisabolol, the highest inhibition levels were observed in M. gypseum at 79.8% and 
83.7%, respectively. Due to this high inhibition activity, we chose M. gypseum for further studies at the 
ultrastructural level to determine morphological changes induced by α-bisabolol. 
In Table 2 are shown the IC50 values of α-bisabolol, in comparison with the well known antifungal 
agent, fluconazole. 
Table 2. IC50 values of α-bisabolol and Fluconazole on dermatophytes. Each value is the 




M. gypseum 35.24 ± 0.9 18.5 ± 0.2 
M. canis >200 29.6 ± 0.3 
T. violaceum >200 31.03 ± 0.9 
N. cajetani 85 ± 0.6 >200 
T. mentagrophytes 60.51 ± 0.3 3.53 ± 0.8 
E. floccosum >200 0.08 ± 0.6 
A. gypseum 81.69 ± 0.4 >200 
T. rubrum >200 37.16 ± 0.6 
T. tonsurans 49.38 ± 0.7 19.41 ± 0.5 
IC50 values confirmed the interesting activity of α-bisabolol, in particular on M. gypseum  
(35.24 μg/mL) and T. tonsurans (49, 38 μg/mL), it is remarkable that on two fungi (N. cajetani and  
A. gypseum) the IC50 was even lower than that of fluconazole. 
2.2. Effect of Time and Spore Density on Percent Reduction of Resazurin 
The effect of spore density and incubation time on reduction of Resazurin, are illustrated in Figure 2. 
The blue color indicates absence of cell viability while the pink color indicates the presence of cell 
viability. It can be seen that the first signs of cell viability appeared at a density of 105 spores/mL and 
after an incubation time at 24 °C of 120 h. We considered these values of spore density and incubation 
time the best for the evaluation of inhibition of spore germination. 
2.3. Inhibition of Spore Germination by Resazurin Assay 
Table 3 presents the values of percent inhibition rate of spore germination with α-bisabolol at the 
concentrations of 100 and 200 μg/mL. It appeared to be a good inhibitor of spore germination at both 
tested doses of 100 and 200 μg/mL (52.08% and 59.32% inhibition respectively). It is noteworthy that 
these small differences in inhibition of spore germination corresponded well with the effect of  
α-bisabolol on growth at both doses (79.8% and 83.7% inhibition respectively). 
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Figure 2. Effect of time and spore density on percent reduction of Resazurin. The highest 
reduction occurred after 120 h of incubation with a spore density of 105 spores. 
Table 3. Percent inhibition values on spore germination. 
α-Bisabolol Concentration %Inhibition of Spore Germination 
100 μg/mL 52.08 ± 0.9 
200 μg/mL 59.32 ± 1.3 
2.4. TEM 
When examined by TEM, the mycelium of the M. gypseum control sample appeared normal: all 
organelles, such as the nucleus and mitochondria, were normally shaped, and the plasma membrane 
was unfolded with a uniform appearance (Figure 3A). 
After 24 h of treatment at the lower α-bisabolol concentration of 100 µg/mL, morphological changes 
were observed. As shown in Figure 3B, the nuclei are irregularly shaped, presenting numerous anomalous 
lobes and invaginations; even the nucleoli appear frayed and not very compact. 
In Figure 4A, after treatment at the higher 200 μg/mL concentration, the outer cell wall presents 
significant abnormalities. In particular, the anomalous formation of numerous and recurring septa are 
visible; the septa often have altered shapes, such as the bifid septum indicated by the arrow. In addition, 
the septa are located in unusual areas. In Figure 4B, there is evidence of the early formation of a septum 
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in the sub apical area, which is a location where parietal components are still in phase of linkage. In the 
same figure, a thick cell wall (indicated by an asterisk) is present in an adjacent cell, made of many 
layers and it is also visible an abnormal extrusion of cell wall materials from the outer layer. 
Finally, increased vacuolization is observed within the cytoplasm after treatment with 200 μg/mL  
of α-bisabolol. 
Figure 3. (A) Untreated control hypha of M. gypseum observed by TEM. The nucleus and 
the cell wall are normally structured; (B) TEM of M. gypseum treated with 100 μg/mL  
α-bisabolol. The nucleus shows deep invaginations. Bar, 1 μm. 
Figure 4. TEM of M. gypseum treated with 200 μg/mL α-bisabolol. (A) Septa are in closer 
proximity with each other and have anomalous shapes; arrow indicates a bifidous septum; 
(B) Arrow indicates the early formation of a septum in the sub apical area; asterisk 
indicates an abnormal multilayer cell wall. Bar, 1 μm. 
Our study shows that, among the nine skin lighteners tested as antifungal agents, α-bisabolol showed 
promising properties, due to its ability to inhibit the growth of all tested dermatophytes, especially  
M. gypseum. The IC50 of α-bisabolol on M. gypseum suggested us to choose this fungus to better 
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understand the antidermatophytic activity. The first step was the evaluation of spore germination 
inhibition with the Resazurin assay. This is a widespread test in agronomy, but only little applied on 
dermatophytes and never used on M. gypseum. So it was necessary to adapt the procedure, by determing 
the right number of spore and the time of germination of this fungus. The results obtained with Resazurin 
assay on spore germination, confirmed the good inhibition activity of α-bisabolol on M. gypseum. 
TEM observations were performed on an α-bisabolol-treated M. gypseum sample to better understand 
the mechanism of action of this anti-fungal agent. Upon treatment with α-bisabolol, several morphological 
abnormalities were observed in M. gypseum. At a low α-bisabolol concentration, the nuclear envelope 
presented numerous lobes, whereas at a higher dose, the aberrations are widespread, even affecting the 
cell wall structure. Both aspects are likely related to altered microtubule behavior. α-Bisabolol may affect 
the dynamic microtubules responsible for maintaining the nuclear shape, causing alterations in the 
nuclear envelope [22,23]. Additionally, it is also possible that α-bisabolol targets the microtubules 
responsible for directing cellular wall materials toward the cell periphery. It is known that MTs and 
other cytoskeleton components are responsible for the normal assembly of parietal components and are 
involved in the transport and release of vesicles containing the construction materials [24]. Disruption 
of the MTs leads to altered vesicle distributions [25] and thus results in the irregular build-up of  
wall materials to apical locations along the cell wall. This proposed mechanism could also explain the 
anomalous septa appearances in the apical zone and the increased concentration of septa. The observed 
effects correspond with the effects of α-bisabolol when used as a biosynthetic inhibitor of ergosterol,  
a sterol specifically located in the membrane of fungi, as suggested by Pauli (2006). In this previous 
study, by comparing the chemical structures of α-bisabolol and zymosterol, Pauli suggested treatment 
with α-bisabolol prevented the formation of fecosterol from zymosterol, which is the first fungi-specific 
step in ergosterol biosynthesis. Thus, α-bisabolol has a mechanism of action common to several antifungal 
drugs [26,27]. 
α-Bisabolol may exists as four different isomers. The natural, pure isomer is the RR (−) enantiomer, 
which can only be extracted from natural origins. While the (−) and (+) racemic mixtures of α-bisabolol 
can be chemically synthesized in the laboratory, the separation of the two enantiomers is economically 
disadvantageous. The racemic mixtures have half the effective biological activity of the pure, naturally 
derived (−)α-bisabolol. 
3. Experimental Section 
3.1. Chemicals 
The tested substances (α-bisabolol, kojic acid, β-arbutin, azelaic acid, hydroquinone, nicotinamide, 
glycine, glutathione and ascorbyl tetraisopalmitate) were purchased from Fagron, API Corporation, 
Res Pharma, Sarfam Comercial Importadora Ltda. (Sao Paolo, SP, Brazil) and Nikko Chemicals Co., 
Ltd. (Tokyo, Japan). 
Fungal culture medium was purchased from Difco Laboratories, Inc. (Becton, Dickinson and 
Company, Cockeysville, MD, USA). 
The chemicals used for fixations and solvents were purchased from Sigma-Aldrich SRL,  
Milano, Italy. 




Seven of the specific fungi strains investigated in this study were purchased from the Centraal 
Bureau voor Schimmelcultures (CBS), Baarn, The Netherlands: Nannizzia cajetani Ajello, strain  
CBS 495.70; Epidermophyton floccosum (Hartz) Langeron and Milochevitch, strain CBS 358.93; 
Trichophyton violaceum Malmsten, strain CBS 459.61; Trichophyton tonsurans Malmsten, strain CBS 
483.76, Trichophyton mentagrophytes (Robin) Blanchard, strain CBS 160.66; Microsporum canis 
Bodin, strain CBS 4727; and Arthroderma gypseum (Nann.) Weitzman, McGinnis, A.A. Padhye and 
Ajello, strain CBS 286.63. The remaining two strains were purchased from the Institute of Hygiene and 
Epidemiology-Mycology Laboratory (IHME), Brussels, Belgium: Trichophyton rubrum (Castellani) 
Sabouraud, strain IHME 4321; Microsporum gypseum (Bodin) Guiart e Grigorakis, strain IHME 3999. 
All dermatophytes were maintained at 4 °C as agar slants on Sabouraud dextrose agar (SDA; Difco 
Laboratories, Inc.). 
3.3. Antifungal Activity 
Antifungal activity was determined as follows. Each test substance was dissolved in dimethylsulfoxide 
(DMSO) and aseptically mixed with sterile medium (SDA) at 45 °C to concentrations of 100 and  
200 μg/mL. The DMSO concentration in the final solution was adjusted to 0.1%. Controls were also 
prepared with equivalent concentrations (0.1% v/v) of DMSO. For experiments, cultures were obtained 
by transplanting mycelium disks (10 mm diameters) from a single mother culture in the stationary 
phase. They were incubated at 26 ± 1 °C on SDA on thin sheets of cellophane until the logarithmic 
growth phase. Subsequently, the cultures were transferred to Petri plates with media containing 100 or 
200 μg/mL of the single substance and incubated under growth conditions. The fungal growth was 
evaluated daily by measuring colony diameters (in millimeters) for seven days from the treatment onset. 
The percent inhibition of growth was determined as the average of three different experiments. 
IC50 values were obtained testing α-bisabolol and Fluconazole against the nine dermatophytes at 
different concentrations: 1, 5, 10, 20, 50 μg/mL for Fluconazole, 5, 10, 20, 50, 100 μg/mL for α-bisabolol. 
IC50 values were determined as the average of three different experiments. 
3.4. Determination of Optimal Spore Concentration-Growth in Sabouraud Dextrose Broth in 
Resazurin Assay 
M. gypseum was grown on Sabouraud Dextrose (SD) agar at 28 °C until sporulation occurs, typically 
for 7–14 days. The spores were harvested in Sabouraud Dextrose (SD) agar from 12 days cultures  
and the numbers of Colony Forming Units (CFU) per mL were determined by plating serial dilutions on 
Sabouraud Dextrose agar plates. 
Subsequently, serial dilutions were made from a first solution containing 6 × 106 spores/mL in 
Sabouraud Dextrose Broth to obtain spore concentrations from 101 to 106 spores/mL. The vials were 
prepared in duplicates for each concentration. Then, 100 μL of a stock solution of Resazurin (Resazurin 
sodium salt, Sigma, stock solution of 0.00675 g/mL of sterile distilled water) was added to test vials. 
Vials were covered, gently rotated horizontally to mix the vial contents, and incubated in the dark at 24 °C. 
At six different incubation times (24, 48, 72, 96, 120 and 144 h) the percent reduction of Resazurin 
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was determined by taking absorbance readings at two wavelengths, 540 and 630 nm. Duplicate 
negative control vials, contained 10 mL of medium and 100 μL of Resazurin only, were made. 
3.5. Evaluation of Inhibition of Spore Germination of α-Bisabolol 
The efficacy of α-bisabolol was evaluated by the Resazurin assay using optimized incubation time and 
spore density. A stock solution of α-bisabolol was prepared in DMSO. Then α-bisabolol was added to 
test vials in duplicate at the concentrations of 20 and 100 μg/mL. Test vials contained α-bisabolol,  
105 spore/mL (determined from previous evaluation), and 100 μL of Resazurin stock solution 
Sabouraud Dextrose Broth. The vials were covered, gently rotated horizontally to mix the content, and 
incubated in the dark at 24 °C for 120 h. Duplicate negative control vials contain 10 mL of medium 
and 100 μL of Resazurin stock solution. Duplicate positive control vials containe 10 mL of medium, 
105 spore/mL, and 100 μL of Resazurin stock solution. 
3.6. Spectrophotometric Measurement and Visual Inspection 
Absorbance data was expressed as percent Resazurin reduced as a function of incubation time. After 
120 h, the percent reduction of Resazurin was determined colorimetrically by taking absorbance 
readings at two wavelengths, 540 and 630 nm, to compensate for an overlap in the absorption spectra 
of the oxidized and reduced forms of the dye [28]). Absorbance was read with a Beckman Coulter TM 
DU® 530, Life Science UV/Vis Spectrophotometer Single cell module. The mean absorbance values 
were used in subsequent calculations. The following Equation (1) was used to calculate the percent 
reduction of Resazurin:  
Percent reduction of Resazurin = [(O2 × A1) − (O1 × A2)]/[(R1 × N2) − (R2× N1)] × 100 (1)
where O1 = molar extinction coefficient (E) of oxidized Resazurin (Blue) at 540 nm, O2 = E of 
oxidized Resazurin at 630 nm, R1= E of reduced Resazurin (Red) at 540 nm, R2 = E of reduced 
Resazurin at 630 nm, A1 = absorbance of test vials at 540 nm, A2 = absorbance of test wells at  
630 nm, N1 = absorbance of negative control vial (media plus Resazurin but no cells) at 540 nm, and 
N2 = absorbance of negative control vial (media plus Resazurin but no cells) at 630 nm. Molar 
extinction coefficients were 540 nm = 104,395, reduced and 47,619, oxidized; and 630 nm = 5494, 
reduced and 34,798, oxidized. 
A blue color was interpreted as absence of metabolic activity (no spore germination). A fluorescent 
pink color was interpreted as presence of metabolic activity (spore germination). A purple color in the 
vials was interpreted as a trailing result where some metabolic activities were present but a longer 
incubation time allowed the purple color to change to pink. 
3.7. Transmission Electron Microscopy (TEM) 
For TEM, the youngest hyphae of M. gypseum were chosen from untreated mycelia and from 
mycelia treated for 24 h with 100 and 200 μg/mL of α-bisabolol. 
The samples were fixed with 6% glutaraldehyde (GA) in a 0.1 M sodium cacodylate buffer, pH 6.8 
for 6 h at 4 °C. After rinsing in the same buffer solution, they were post-fixed for 15 h with 1% osmium 
tetroxide (OsO4) in the same buffer, dehydrated in a graded series of ethanol solutions and embedded 
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in Epon-Araldite resin. Sections were cut with an LKB Ultratome III, stained with uranyl acetate and 
lead citrate and observed under a Hitachi H-800 electron microscope at 100 kV (provided by the 
Electron Microscopy Center of Ferrara University). 
4. Conclusions 
In conclusion, we have shown that α-bisabolol, a natural product present in many preparations 
intended for cosmetic and dermatological uses, possesses significant antifungal activity in vitro, against 
dermatophytes. This property suggests its applicability, within a multidrug approach, for the treatment of 
dermatomycoses, which are especially persistent diseases in immunocompromised hosts [20]. Ongoing 
studies are now evaluating the synergistic combination of α-bisabolol with traditional antifungal agents 
for the treatment of dermatophytoses, and antifungal activity against other pathogenic fungi. Although 
many antifungals are available, their side effects and drug interactions, and the existence of resistant 
organisms have created a need to find safer and more effective treatments. Cytotoxicity assay will be 
performed to assess the selectivity of the compound in the same conditions as the antifungal test. 
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